SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-049737
Filing Date
2020-04-22
Accepted
2020-04-22 16:30:16
Documents
6
Period of Report
2020-06-04
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2016187-2_def14a.htm DEF 14A 610782
2 GRAPHIC lg_caratherapeutics-fpo.jpg GRAPHIC 82701
3 GRAPHIC sg_derekchalmers-fpo.jpg GRAPHIC 20511
4 GRAPHIC sg_scottterrillion-fpo.jpg GRAPHIC 23524
5 GRAPHIC tm2016187d2_pc1.jpg GRAPHIC 586130
6 GRAPHIC tm2016187d2_pc2.jpg GRAPHIC 427349
  Complete submission text file 0001104659-20-049737.txt   2182487
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36279 | Film No.: 20808213
SIC: 2834 Pharmaceutical Preparations